U.S. Rep. Morgan Griffith (R-VA) and Rep. Angie Craig (D-MN) have reintroduced two bills in the U.S. House that would require the Food and Drug Administration to regulate hemp-derived CBD.

The FDA said it does not intend to pursue rulemaking around the inclusion of CBD in dietary supplements or conventional food, but it is prepared to work with Congress on the issue.

The U.S. Food and Drug Administration has issued warning letters to five companies for selling products labeled as containing delta-8-THC in ways that violate the federal Food, Drug, and Cosmetic Act. 

With cannabis-derived products outpacing the existing science and imposing massive health concerns, in October 2021 the FDA issued a “Cannabis-derived products data acceleration plan” to detect safety signals and accelerate research studies.

The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.

Citing a lack of scientific information, the U.S. Food and Drug Administration said it can’t conclude that CBD is generally recognized as safe (GRAS) for use in human or animal food.